RayBiotech Providing Biomarker Services to Fox Chase Cancer Center | GenomeWeb

NEW YORK (GenomeWeb News) – RayBiotech announced on Tuesday a partnership to provide biomarker discovery and validation services to the Fox Chase Cancer Center.

The deal with the center's Genomics Core Facility also will provide RayBiotech's GMP-compliant and ISO 13485:2003-certified diagnostic discovery products to researchers throughout Fox Chase's campus. The services and products are based on RayBiotech's antibody array and ELISA product lines, the Norcross, Ga.-based firm said, adding Fox Chase is receiving preferred pricing as part of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.